Prospect Eval of Efficacy of CMV-TCIP Direct Letermovir Prophylax After Allogen Hemato Cell Transpla
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Irvine
- Dates
- study startedcompletion around
- Principal Investigator
- by Piyanuch Kongtim (uci)
Description
Summary
Official Title
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Piyanuch Kongtim (uci)
Associate Clinical Professor, Medicine, School of Medicine. Authored (or co-authored) 58 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, Irvine
- ID
- NCT06453460
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 50 study participants
- Last Updated